Heikki Joensuu

发表

Evaluation of a web-based system for survival estimation in breast cancer

Mikael Lundin, Johan Lundin, Jorma Isola, 2003, MIE.

Validation of a web-based prognostic system for breast cancer

Mikael Lundin, Johan Lundin, Jorma Isola, 2004, MedInfo.

Comparison of solution-based exome capture methods for next generation sequencing

Heikki Joensuu, Anna-Maija Sulonen, Pekka Ellonen, 2011, Genome Biology.

Soluble syndecan-1 and serum basic fibroblast growth factor are new prognostic factors in lung cancer.

Heikki Joensuu, H. Joensuu, M. Eriksson, 2002, Cancer research.

Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases

Heikki Joensuu, Richard Herrmann, J. Fletcher, 2008, Clinical Cancer Research.

Gastrointestinal stromal tumor: a method for optimizing the timing of CT scans in the follow-up of cancer patients.

Aki Vehtari, Heikki Joensuu, Aki Vehtari, 2014, Radiology.

Regorafenib for patients with previously untreated metastatic or unresectable renal-cell carcinoma: a single-group phase 2 trial.

Michael Jeffers, Heikki Joensuu, Tim Eisen, 2012, The Lancet. Oncology.

Acute myeloid leukemia following Hodgkin lymphoma: a population-based study of 35,511 patients.

Heikki Joensuu, Eero Pukkala, Per Hall, 2006, Journal of the National Cancer Institute.

Sparing of the submandibular glands by intensity modulated radiotherapy in the treatment of head and neck cancer.

Heikki Joensuu, Mikko Tenhunen, Aki Kangasmäki, 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Treatment of inoperable gastrointestinal stromal tumor (GIST) with Imatinib (Glivec, Gleevec).

Heikki Joensuu, H. Joensuu, 2002, Medizinische Klinik.

Intensity modulated radiotherapy for head and neck cancer: evidence for preserved salivary gland function.

Heikki Joensuu, Mikko Tenhunen, Tuomo Hämäläinen, 2005, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Breast cancer outcome prediction with tumour tissue images and machine learning

Riku Turkki, Nina Linder, Mikael Lundin, 2019, Breast Cancer Research and Treatment.

Gene amplification, mutation, and protein expression of EGFR and mutations of ERBB2 in serous ovarian carcinoma

Jorma Isola, Heikki Joensuu, J. Isola, 2006, Journal of Molecular Medicine.

Tumor-Infiltrating Lymphocytes and Prognosis: A Pooled Individual Patient Analysis of Early-Stage Triple-Negative Breast Cancers.

Heikki Joensuu, Carsten Denkert, Damien Drubay, 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Response: Re: Second Cancers Among 104760 Survivors of Cervical Cancer: Evaluation of Long-Term Risk

Heikki Joensuu, Eero Pukkala, Per Hall, 2008 .

Automated classification of breast cancer morphology in histopathological images

Matti Pietikäinen, Esa Rahtu, Ville Ojansivu, 2013, Diagnostic Pathology.

Gastrointestinal stromal tumour

Heikki Joensuu, Peter Hohenberger, H. Joensuu, 2013, The Lancet.

A Patient-Centered Methodology That Improves the Accuracy of Prognostic Predictions in Cancer

Heikki Joensuu, H. Joensuu, M. Kashani-Sabet, 2013, PloS one.

Adjuvant docetaxel or vinorelbine with or without trastuzumab for breast cancer.

Jorma Isola, Heikki Joensuu, Vesa Kataja, 2006, The New England journal of medicine.

Florodeoxyglucose imaging: A method to assess the proliferative activity of human cancer in vivo. Comparison with DNA flow cytometry in head and neck tumors

Heikki Joensuu, Heikki Minn, H. Minn, 1988 .

A web-based system for individualised survival estimation in breast cancer

Mikael Lundin, Johan Lundin, Jorma Isola, 2003, BMJ : British Medical Journal.

Generalizability of survival estimates for patients with breast cancer — a comparison across two population-based series

Mikael Lundin, Johan Lundin, Jorma Isola, 2006 .

Practical management of tyrosine kinase inhibitor-associated side effects in GIST.

Heikki Joensuu, H. Joensuu, P. Reichardt, 2011, Cancer treatment reviews.

Novel Target for Peptide-Based Imaging and Treatment of Brain Tumors

Heikki Joensuu, Ale Närvänen, Ulo Langel, 2014, Molecular Cancer Therapeutics.

Normal stroma suppresses cancer cell proliferation via mechanosensitive regulation of JMJD1a-mediated transcription

Heikki Joensuu, Timo Betz, Pirkko-Liisa Kellokumpu-Lehtinen, 2016, Nature Communications.

Development and evaluation of a virtual microscopy application for automated assessment of Ki-67 expression in breast cancer

Mikael Lundin, Johan Lundin, Jorma Isola, 2011, BMC clinical pathology.

Amplification of erbB2 and erbB2 expression are superior to estrogen receptor status as risk factors for distant recurrence in pT1N0M0 breast cancer: a nationwide population-based study.

Mikael Lundin, Johan Lundin, Jorma Isola, 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

Fluorouracil, epirubicin, and cyclophosphamide with either docetaxel or vinorelbine, with or without trastuzumab, as adjuvant treatments of breast cancer: final results of the FinHer Trial.

Jorma Isola, Heikki Joensuu, Vesa Kataja, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Generalisability of survival estimates for patients with breast cancer--a comparison across two population-based series.

Mikael Lundin, Johan Lundin, Jorma Isola, 2006, European journal of cancer.

Late radiation effects in the dog brain: correlation of MRI and histological changes.

Heikki Joensuu, Merja Kallio, Raimo Joensuu, 2002, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.